Description: Although stroke remains the fifth leading cause of death and the number one cause of serious long-term disability in the US, effective acute treatments (thrombolysis and thrombectomy) that reduce death and disability are available and indications keep expanding and evolving. Through case-based presentations and overview of current evidence, faculty will provide emerging applications of interventional treatments. This session with cover important topics, in particular: 1) preclinical and translational thrombolytic therapies; 2) advances in neuroimaging to define the ischemic core and penumbra; and 3) the continuously evolving role of flow diverting stents.

Chair: Diogo C. Haussen, MD, Emory University

Co-Chair: Alexandra Czap, MD, McGovern Medical School, University of Texas Health Science Center at Houston

Objective(s):

• Understand the future of thrombolytic therapies and the barriers to stroke treatment
• Review advances in neuroimaging to improve accuracy of patient triage and treatment
• Learn why large necked aneurysms were difficult to treat and how flow diverting stents revolutionized this landscape

Presentations:

Novel Preclinical Therapies for Thrombolysis

Speaker:

Shahid Nimjee, MD, PhD

The Ohio State University, Medical Center

Determination of the Ischemic Core

Speaker:

Seena Dehkharghani, MD

New York University, Langone Health

Flow Diverting Stents: Aneurysms and Beyond

Speaker: 

Maxim Mokin, MD, PhD

University of South Florida

Safety and Efficacy of Endovascular Therapy Referred by Telephone-based vs In-person Consultations

Oral Presenter: 

Sarah Nelson, MD, PhD

Mount Sinai Health System